Dural Graft-Induced Fibrotic Mass Twelve Years after Successful Treatment of Skull Base Non-Hodgkin Lymphoma Mimicking Recurrence: Case Report and Literature Review
Affiliation(s)
Department of Neurosurgery, Ninewells Hospital, Dundee, UK. Department of Neurosurgery, Institute of Neurological Science, Glasgow, UK.
Department of Neurosurgery, Ninewells Hospital, Dundee, UK. Department of Neurosurgery, Institute of Neurological Science, Glasgow, UK.
ABSTRACT
Non-Hodgkin lymphoma involving the skull base is a very rare tumour. The role of surgery for these patients remains controversial, as is the use of dural graft for CSF leak repair. With an increasing incidence of CNS lymphoma, more atypical presentations are reported. It is, therefore, important to include lymphoma in the differential diagnosis of skull base lesions as long-term remission is achievable for such patients, as shown in our case. Dural graft used for CSF leak repair could present with delayed complication mimicking tumour recurrence. Relevant published literature is reviewed.
Non-Hodgkin lymphoma involving the skull base is a very rare tumour. The role of surgery for these patients remains controversial, as is the use of dural graft for CSF leak repair. With an increasing incidence of CNS lymphoma, more atypical presentations are reported. It is, therefore, important to include lymphoma in the differential diagnosis of skull base lesions as long-term remission is achievable for such patients, as shown in our case. Dural graft used for CSF leak repair could present with delayed complication mimicking tumour recurrence. Relevant published literature is reviewed.
Cite this paper
M. Teo, S. Martin, J. Bowness and M. Eljamel, "Dural Graft-Induced Fibrotic Mass Twelve Years after Successful Treatment of Skull Base Non-Hodgkin Lymphoma Mimicking Recurrence: Case Report and Literature Review," Open Journal of Modern Neurosurgery, Vol. 4 No. 1, 2014, pp. 7-12. doi: 10.4236/ojmn.2014.41002.
M. Teo, S. Martin, J. Bowness and M. Eljamel, "Dural Graft-Induced Fibrotic Mass Twelve Years after Successful Treatment of Skull Base Non-Hodgkin Lymphoma Mimicking Recurrence: Case Report and Literature Review," Open Journal of Modern Neurosurgery, Vol. 4 No. 1, 2014, pp. 7-12. doi: 10.4236/ojmn.2014.41002.
References
[1] T. L. Helle, R. H. Britt and T. V. Colby, “Primary Lymphoma of the Central Nervous System: Clinopathological Study of Experience at Stanford,” Journal of Neurosurgery, Vol. 60, No. 1, 1984, pp. 94-103. http://dx.doi.org/10.3171/jns.1984.60.1.0094 [2] F. H. Hochberg and D. C. Miller, “Primary Central Nervous System Lymphoma,” Journal of Neurosurgery, Vol. 68, No. 6, 1988, pp. 835-853. http://dx.doi.org/10.3171/jns.1988.68.6.0835 [3] N. L. Eby, S. Gufferman, C. M. Flannelly, S. C. Schold, F. S. Vogel and P. C. Burger, “Increasing Incidence of Primary Brain Lymphoma in the US,” Cancer, Vol. 62, No. 11, 1988, pp. 2461-2465. http://dx.doi.org/10.1002/1097-0142(19881201)62:11<2461::AID-CNCR2820621135>3.0.CO;2-M [4] F. J. Hans, M. H. Reinges, K. Nolte, P. Reipke and T. Krings, “Primary Lymphoma of the Skull Base,” Neuroradiology, Vol. 47, No. 7, 2005, pp. 539-542. http://dx.doi.org/10.1007/s00234-005-1394-4 [5] O. Dare, R. V. Datta, T. R. Loree, W. L. Hicks and W. Grand, “Sinonasal Non-Hodgkin’s Lymphoma with Skull Base Involvement,” Skull Base, Vol. 11, No. 2, 2001, pp. 129-135. http://dx.doi.org/10.1055/s-2001-14433 [6] S. Jung, M. Zimmermann and V. Seifert, “Clivus Lymphoma,” Acta Neurochirurgica, Vol. 146, No. 5, 2004, pp. 533-534. http://dx.doi.org/10.1007/s00701-004-0244-1 [7] S. M. Roman-Goldstein, A. Jones, J. B. Delashaw, S. Mc-Menomey and E. A. Neuwelt, “Atypical Central Nervous System Lymphoma at the Cranial Base: Report of Four Cases,” Neurosurgery, Vol. 43, No. 3, 1998, pp. 613-615. http://dx.doi.org/10.1097/00006123-199809000-00119 [8] K. Jaiswal, M. Tripathi, P. S. Chandra, M. C. Sharma and A. K. Maha-patra, “An Unusual Case of Primary Lymphoma of the Skull Base Extending from Cerebellopontine Angle to Cavernous Sinus and Orbit. A Case Report,” Journal Neurosurg Science, Vol. 44, No. 3, 2000, pp. 145-148. [9] J. M. Henry, R. R. Heffner, S. H. Diiard, K. M. Earle and R. L. Davis, “Primary Malignant Lymphomas of the Central Nervous System,” Cancer, Vol. 34, No. 4, 1974, pp. 1293-1302.
http://dx.doi.org/10.1002/1097-0142(197410)34:4<1293::AIDCNCR2820340441>3.0.CO;2-P [10] H. Oyama, M. Nagane, S. Shibui, K. Nomura and K. Mukai, “Skull Base Malignant Lymphoma: A Case Report and Review of the Literature,” Japanese Journal of Clinical Oncology, Vol. 22, No. 2, 1992, pp. 131-135. [11] M. Shibata, M. Shimoda and O. Sato, “A Case of Bilateral Panopthalmoplegia Caused by Paranasal Malignant Lymphoma Extending into the Skull Base,” No Shinkei Geka, Vol. 20, No. 6, 1992, pp. 717-721. [12] S. Tanaka, H. Nihei, S. Manaka and T. Hori, “A Case of Malignant Lymphoma in the Skull Base,” No Shinkei Geka, Vol. 22, No. 1, 1994, pp. 73-78. [13] V. W. Tsai, L. Rybak, J. Espinosa, M. J. Kuhn, O. W. Kamel, F. Mathews and F. R. Glatz, “Primary B-Cell Lymphoma of the Clivus: Case Report,” Surgical Neurology, Vol. 58, No. 3-4, 2002, pp. 246-250. http://dx.doi.org/10.1016/S0090-3019(02)00845-5 [14] K. G. Davies, G. C. Cole and R. D. Weeks, “Twenty Year Survival Following Excision of Primary CNS Lymphoma without Radiation Therapy: Case Report,” British Journal of Neurosurgery, Vol. 8, No. 4, 1994, pp. 487-491. http://dx.doi.org/10.3109/02688699408995120 [15] W. Sonstein, K. Tabaddor and J. F. Ilena, “Solitary Primary CNS Lymphoma: Long Term Survival Following Total Re-section,” Medical Oncology, Vol. 15, No. 1, 1998, pp. 61-65.
http://dx.doi.org/10.1007/BF02787347 [16] S. A. Leibel and G. E. Sheline, “Radiation Therapy for Neoplasms of the Brain,” Journal of Neurosurgery, Vol. 66, No. 1, 1987, pp. 1-22. http://dx.doi.org/10.3171/jns.1987.66.1.0001 [17] D. F. Nelson, K. L. Martz, H. Bonner H, J. S. Nelson, J. Newall, H. D. Kerman, J. W. Thomson and K. J. Murray, “Non-Hodgkin’s Lymphoma of the Brain: Can High Dose, Large Volume Radiation Therapy Improve Survival? Report on a Prospective Trial by the Radiation Therapy Oncolgy Group (RTOG): RTOG 8315,” International Journal of Radiation Oncology, Biology, Physics, Vol. 23, No. 1, 1992, pp. 9-17. http://dx.doi.org/10.1016/0360-3016(92)90538-S [18] J. Y. Blay, T. Conroy, C. Chevreau, A. Thyss, N. Quesnel, H. Eghbali, R. Bouabdallah, B. Coiffier, J. P. Wagner, A. Le Mevel, D. Dramais-Marcel, “High-Dose Methotrexate for the Treatment of Primary Cerebral Lymphomas: An Analysis of Survival and Late Neurological Toxicity in a Retrospective Series,” Journal of Clinical Oncology, Vol. 16, No. 3, 1998, pp. 864-871. [19] M. Brada, D. Dearnaley, A. Horwich and H. J. G. Bloom, “Management of Primary Cerebral Lymphoma with Initial Chemotherapy: Preliminary Results and Comparison with Patients Treated with Radiotherapy Alone,” International Journal Radiation, Oncology, Biology, Physics, Vol. 18, No. 4, 1990, pp. 787-792. http://dx.doi.org/10.1016/0360-3016(90)90398-4 [20] L. M. DeAngelis, J. Yahalom, H. Thaler and U. Kher, “Combined Modality Therapy for Primary CNS Lymphoma,” Journal of Clinical Oncology, Vol. 10, No. 4, 1992, pp. 635-643. [21] T. Banerjee, J. N. Mergher and W. E. Hunt, “Unusual Complications with use of Silastic Dural Substitute,” The American Surgeon, Vol. 40, No. 7, 1974, pp. 434-437. [22] W. S. Fisher and E. G. Six, “Cervical Myelopathy from Dural Substitute,” Neurosurgery, Vol. 13, No. 6, 1983, pp. 715-716. http://dx.doi.org/10.1227/00006123-198312000-00020 [23] J. T. Keller, C. M. Ongkiko, M. C. Saunders, F. H. Mayfield and S. B. Dunsker, “Repair of Spinal Defects: An Experimental Study,” Journal of Neurosurgery, Vol. 60, No. 5, 1984, pp. 1022-1028.
http://dx.doi.org/10.3171/jns.1984.60.5.1022 [24] S. Robertson and A. Menezes, “Hemorrhagic Complications in Association with Silastic Dural Substitute: Pediatric and Adult Case Reports with a Review of the Literature,” Neurosurgery, Vol. 40, No. 1, 1997, pp. 201-206. [25] E. E. Awwad, K. R. Smith Jr., D. S. Martin and A. Manepalli A, “Unusual Hemorrhage with Use of Synthetic Dural Substitute: MR findings,” Journal of Computer Assisted Tomography, Vol. 15, No. 4, 1991, pp. 618-620. http://dx.doi.org/10.1097/00004728-199107000-00017 [26] N. R. Berrington, “Acute Extradural Hematoma Associated with Silastic Dural Substitute: Case Report,” Surgical Neurology, Vol. 38, No. 6, 1992, pp. 469-470. http://dx.doi.org/10.1016/0090-3019(92)90117-6 [27] G. Gondo, S. Nakayama, Y. Mochimatsu, F. Nakajima and A. Hasegawa, “Posterior Fossa Hemorrhage 11 Years after the Use of Silastic Dural Substitute: Case Report,” No Shinkei Geka, Vol. 19, No. 1, 1991, pp. 59-62. [28] D. Siccardi and A. Ventimiglia, “Fibrotic-Haemorrhagic Reaction to Synthetic Dural Substitute,” Acta Neurochirurgica, Vol. 132, No. 1-3, 1995, pp. 148-149. http://dx.doi.org/10.1007/BF01404864 [29] D. Simpson and A. Robson, “Recurrent Subarachnoid Bleeding in Association with Dural Substitute: Report of Three Cases,” Journal of Neurosurgery, Vol. 60, No. 2, 1984, pp. 408-409.
http://dx.doi.org/10.3171/jns.1984.60.2.0408 [30] N. Ohbayashi, T. Inagawa, Y. Katoh, K. Kumano, R. Nagasako and H. Hada, “Complication of Silastic Dural Substitute 20 Years after Dural Plasty,” Surgical Neurology, Vol. 41, No. 4, 1994, pp. 338-341. http://dx.doi.org/10.1016/0090-3019(94)90187-2 [31] R. Cohen, S. Aleksic and J. Ransohoff, “Inflammatory Reaction to Synthetic Dural Substitute: Case Report,” Journal of Neurosurgery, Vol. 70, No. 4, 1989, pp. 633-635.
http://dx.doi.org/10.3171/jns.1989.70.4.0633 [32] R. L. Friede and W. Schachenmayr, “The Origin of Subdural Neomembranes: II—Fine Structures of Neomembranes,” pp. 69-84. [33] W. Schachenmayr and R. L. Friede, “The Origin of Subdural Neomembranes: I—Fine Structures of the Dura-arachnoid Interface in Man,” American Journal of Pathology, Vol. 92, No. 1, 1978, pp. 53-68. [34] G. I. Schoefl, “Studies in Inflammation: III—Growing Capillaries: Their Structure and Permeability,” Virchows Archiv für pathologische Anatomie und Physiologie und für klinische Medizin, Vol. 337, No. 2, 1963, pp. 97-141. http://dx.doi.org/10.1007/BF00963592
[1] T. L. Helle, R. H. Britt and T. V. Colby, “Primary Lymphoma of the Central Nervous System: Clinopathological Study of Experience at Stanford,” Journal of Neurosurgery, Vol. 60, No. 1, 1984, pp. 94-103. http://dx.doi.org/10.3171/jns.1984.60.1.0094 [2] F. H. Hochberg and D. C. Miller, “Primary Central Nervous System Lymphoma,” Journal of Neurosurgery, Vol. 68, No. 6, 1988, pp. 835-853. http://dx.doi.org/10.3171/jns.1988.68.6.0835 [3] N. L. Eby, S. Gufferman, C. M. Flannelly, S. C. Schold, F. S. Vogel and P. C. Burger, “Increasing Incidence of Primary Brain Lymphoma in the US,” Cancer, Vol. 62, No. 11, 1988, pp. 2461-2465. http://dx.doi.org/10.1002/1097-0142(19881201)62:11<2461::AID-CNCR2820621135>3.0.CO;2-M [4] F. J. Hans, M. H. Reinges, K. Nolte, P. Reipke and T. Krings, “Primary Lymphoma of the Skull Base,” Neuroradiology, Vol. 47, No. 7, 2005, pp. 539-542. http://dx.doi.org/10.1007/s00234-005-1394-4 [5] O. Dare, R. V. Datta, T. R. Loree, W. L. Hicks and W. Grand, “Sinonasal Non-Hodgkin’s Lymphoma with Skull Base Involvement,” Skull Base, Vol. 11, No. 2, 2001, pp. 129-135. http://dx.doi.org/10.1055/s-2001-14433 [6] S. Jung, M. Zimmermann and V. Seifert, “Clivus Lymphoma,” Acta Neurochirurgica, Vol. 146, No. 5, 2004, pp. 533-534. http://dx.doi.org/10.1007/s00701-004-0244-1 [7] S. M. Roman-Goldstein, A. Jones, J. B. Delashaw, S. Mc-Menomey and E. A. Neuwelt, “Atypical Central Nervous System Lymphoma at the Cranial Base: Report of Four Cases,” Neurosurgery, Vol. 43, No. 3, 1998, pp. 613-615. http://dx.doi.org/10.1097/00006123-199809000-00119 [8] K. Jaiswal, M. Tripathi, P. S. Chandra, M. C. Sharma and A. K. Maha-patra, “An Unusual Case of Primary Lymphoma of the Skull Base Extending from Cerebellopontine Angle to Cavernous Sinus and Orbit. A Case Report,” Journal Neurosurg Science, Vol. 44, No. 3, 2000, pp. 145-148. [9] J. M. Henry, R. R. Heffner, S. H. Diiard, K. M. Earle and R. L. Davis, “Primary Malignant Lymphomas of the Central Nervous System,” Cancer, Vol. 34, No. 4, 1974, pp. 1293-1302.
http://dx.doi.org/10.1002/1097-0142(197410)34:4<1293::AIDCNCR2820340441>3.0.CO;2-P [10] H. Oyama, M. Nagane, S. Shibui, K. Nomura and K. Mukai, “Skull Base Malignant Lymphoma: A Case Report and Review of the Literature,” Japanese Journal of Clinical Oncology, Vol. 22, No. 2, 1992, pp. 131-135. [11] M. Shibata, M. Shimoda and O. Sato, “A Case of Bilateral Panopthalmoplegia Caused by Paranasal Malignant Lymphoma Extending into the Skull Base,” No Shinkei Geka, Vol. 20, No. 6, 1992, pp. 717-721. [12] S. Tanaka, H. Nihei, S. Manaka and T. Hori, “A Case of Malignant Lymphoma in the Skull Base,” No Shinkei Geka, Vol. 22, No. 1, 1994, pp. 73-78. [13] V. W. Tsai, L. Rybak, J. Espinosa, M. J. Kuhn, O. W. Kamel, F. Mathews and F. R. Glatz, “Primary B-Cell Lymphoma of the Clivus: Case Report,” Surgical Neurology, Vol. 58, No. 3-4, 2002, pp. 246-250. http://dx.doi.org/10.1016/S0090-3019(02)00845-5 [14] K. G. Davies, G. C. Cole and R. D. Weeks, “Twenty Year Survival Following Excision of Primary CNS Lymphoma without Radiation Therapy: Case Report,” British Journal of Neurosurgery, Vol. 8, No. 4, 1994, pp. 487-491. http://dx.doi.org/10.3109/02688699408995120 [15] W. Sonstein, K. Tabaddor and J. F. Ilena, “Solitary Primary CNS Lymphoma: Long Term Survival Following Total Re-section,” Medical Oncology, Vol. 15, No. 1, 1998, pp. 61-65.
http://dx.doi.org/10.1007/BF02787347 [16] S. A. Leibel and G. E. Sheline, “Radiation Therapy for Neoplasms of the Brain,” Journal of Neurosurgery, Vol. 66, No. 1, 1987, pp. 1-22. http://dx.doi.org/10.3171/jns.1987.66.1.0001 [17] D. F. Nelson, K. L. Martz, H. Bonner H, J. S. Nelson, J. Newall, H. D. Kerman, J. W. Thomson and K. J. Murray, “Non-Hodgkin’s Lymphoma of the Brain: Can High Dose, Large Volume Radiation Therapy Improve Survival? Report on a Prospective Trial by the Radiation Therapy Oncolgy Group (RTOG): RTOG 8315,” International Journal of Radiation Oncology, Biology, Physics, Vol. 23, No. 1, 1992, pp. 9-17. http://dx.doi.org/10.1016/0360-3016(92)90538-S [18] J. Y. Blay, T. Conroy, C. Chevreau, A. Thyss, N. Quesnel, H. Eghbali, R. Bouabdallah, B. Coiffier, J. P. Wagner, A. Le Mevel, D. Dramais-Marcel, “High-Dose Methotrexate for the Treatment of Primary Cerebral Lymphomas: An Analysis of Survival and Late Neurological Toxicity in a Retrospective Series,” Journal of Clinical Oncology, Vol. 16, No. 3, 1998, pp. 864-871. [19] M. Brada, D. Dearnaley, A. Horwich and H. J. G. Bloom, “Management of Primary Cerebral Lymphoma with Initial Chemotherapy: Preliminary Results and Comparison with Patients Treated with Radiotherapy Alone,” International Journal Radiation, Oncology, Biology, Physics, Vol. 18, No. 4, 1990, pp. 787-792. http://dx.doi.org/10.1016/0360-3016(90)90398-4 [20] L. M. DeAngelis, J. Yahalom, H. Thaler and U. Kher, “Combined Modality Therapy for Primary CNS Lymphoma,” Journal of Clinical Oncology, Vol. 10, No. 4, 1992, pp. 635-643. [21] T. Banerjee, J. N. Mergher and W. E. Hunt, “Unusual Complications with use of Silastic Dural Substitute,” The American Surgeon, Vol. 40, No. 7, 1974, pp. 434-437. [22] W. S. Fisher and E. G. Six, “Cervical Myelopathy from Dural Substitute,” Neurosurgery, Vol. 13, No. 6, 1983, pp. 715-716. http://dx.doi.org/10.1227/00006123-198312000-00020 [23] J. T. Keller, C. M. Ongkiko, M. C. Saunders, F. H. Mayfield and S. B. Dunsker, “Repair of Spinal Defects: An Experimental Study,” Journal of Neurosurgery, Vol. 60, No. 5, 1984, pp. 1022-1028.
http://dx.doi.org/10.3171/jns.1984.60.5.1022 [24] S. Robertson and A. Menezes, “Hemorrhagic Complications in Association with Silastic Dural Substitute: Pediatric and Adult Case Reports with a Review of the Literature,” Neurosurgery, Vol. 40, No. 1, 1997, pp. 201-206. [25] E. E. Awwad, K. R. Smith Jr., D. S. Martin and A. Manepalli A, “Unusual Hemorrhage with Use of Synthetic Dural Substitute: MR findings,” Journal of Computer Assisted Tomography, Vol. 15, No. 4, 1991, pp. 618-620. http://dx.doi.org/10.1097/00004728-199107000-00017 [26] N. R. Berrington, “Acute Extradural Hematoma Associated with Silastic Dural Substitute: Case Report,” Surgical Neurology, Vol. 38, No. 6, 1992, pp. 469-470. http://dx.doi.org/10.1016/0090-3019(92)90117-6 [27] G. Gondo, S. Nakayama, Y. Mochimatsu, F. Nakajima and A. Hasegawa, “Posterior Fossa Hemorrhage 11 Years after the Use of Silastic Dural Substitute: Case Report,” No Shinkei Geka, Vol. 19, No. 1, 1991, pp. 59-62. [28] D. Siccardi and A. Ventimiglia, “Fibrotic-Haemorrhagic Reaction to Synthetic Dural Substitute,” Acta Neurochirurgica, Vol. 132, No. 1-3, 1995, pp. 148-149. http://dx.doi.org/10.1007/BF01404864 [29] D. Simpson and A. Robson, “Recurrent Subarachnoid Bleeding in Association with Dural Substitute: Report of Three Cases,” Journal of Neurosurgery, Vol. 60, No. 2, 1984, pp. 408-409.
http://dx.doi.org/10.3171/jns.1984.60.2.0408 [30] N. Ohbayashi, T. Inagawa, Y. Katoh, K. Kumano, R. Nagasako and H. Hada, “Complication of Silastic Dural Substitute 20 Years after Dural Plasty,” Surgical Neurology, Vol. 41, No. 4, 1994, pp. 338-341. http://dx.doi.org/10.1016/0090-3019(94)90187-2 [31] R. Cohen, S. Aleksic and J. Ransohoff, “Inflammatory Reaction to Synthetic Dural Substitute: Case Report,” Journal of Neurosurgery, Vol. 70, No. 4, 1989, pp. 633-635.
http://dx.doi.org/10.3171/jns.1989.70.4.0633 [32] R. L. Friede and W. Schachenmayr, “The Origin of Subdural Neomembranes: II—Fine Structures of Neomembranes,” pp. 69-84. [33] W. Schachenmayr and R. L. Friede, “The Origin of Subdural Neomembranes: I—Fine Structures of the Dura-arachnoid Interface in Man,” American Journal of Pathology, Vol. 92, No. 1, 1978, pp. 53-68. [34] G. I. Schoefl, “Studies in Inflammation: III—Growing Capillaries: Their Structure and Permeability,” Virchows Archiv für pathologische Anatomie und Physiologie und für klinische Medizin, Vol. 337, No. 2, 1963, pp. 97-141. http://dx.doi.org/10.1007/BF00963592